← Back to Clinical Trials
Recruiting NCT05051917

NCT05051917 The Italian Coronary Artery Aneurysm and Ectasia In Patients With Acute Coronary Syndrome

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05051917
Status Recruiting
Phase
Sponsor Federico II University
Condition Acute Coronary Syndrome
Study Type OBSERVATIONAL
Enrollment 500 participants
Start Date 2021-09-01
Primary Completion 2024-09-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 500 participants in total. It began in 2021-09-01 with a primary completion date of 2024-09-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The ITACA study is a prospective, observational no profit registry enrolling patients with Acute Coronary Syndrome and angiographic evidence of coronary aneurysms and/or ectasia.

Eligibility Criteria

Inclusion Criteria: * Signature of informed consent; * Patients aged ≥18 years; * diagnosis of ACS (ST-elevation myocardial infarction, non ST-elevation myocardial infarction, unstable angina), in accordance with the definition provided in the latest guidelines; * diagnosis of ectasia or coronary aneurysm according to the definitions contained in this protocol, either in the culprit vessel of the SCA than in another vessel. Coronary pseudoaneurysms are excluded. Exclusion Criteria: * impossibility or unwillingness to provide signed informed consent; * contraindications to dual antiplatelet therapy; * contraindications to anticoagulant therapy; * active bleeding or severe anemia (Hb \<6 g / dl); * life expectancy \<12 months; * female patients with potential pregnancy;

Frequently Asked Questions

Who can join the NCT05051917 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Coronary Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05051917 currently recruiting?

Yes, NCT05051917 is actively recruiting participants. Visit ClinicalTrials.gov or contact Federico II University to inquire about joining.

Where is the NCT05051917 trial being conducted?

This trial is being conducted at Forlì, Italy, Naples, Italy.

Who is sponsoring the NCT05051917 clinical trial?

NCT05051917 is sponsored by Federico II University. The trial plans to enroll 500 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology